Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 11 » 1st World Lung Disease Summit

Highlights and hot topics in the management of COPD: where are we heading?

Authors Agustí A, Jones P, Vogelmeier C, Finch D

Received 10 April 2015

Accepted for publication 6 May 2015

Published 18 February 2016 Volume 2016:11(1st World Lung Disease Summit) Pages 1—2

DOI https://doi.org/10.2147/COPD.S85975

Checked for plagiarism Yes

Editor who approved publication: Dr Richard Russell


Alvar Agustí,1 Paul W Jones,2 Claus Vogelmeier3

1Thorax Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain; 2Division of Clinical Science, St George’s, University of London, London, UK; 3Department for Pulmonary Medicine, Philipps-University of Marburg, Marburg, Germany

Proceedings of the First World Lung Disease Summit, Lisbon, Portugal, November 2013
The First World Lung Disease Summit took place in Lisbon over two days in November 2013. This inaugural meeting, of what is hoped to be a long-running annual series, brought together experts in respiratory medicine to explore many of the issues and challenges faced by clinicians when managing lung diseases, particularly asthma and COPD. The aim of the series is to present and discuss innovative science through a scientifically balanced program, and to explore how recent developments can inform clinical practice and improve patient care. The program for the inaugural meeting emphasized ongoing work in basic, clinical, and translational science as it evolves to bring about a more complete understanding of the pathology of asthma and COPD.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]